Genesis Energy, L.P. (GEL)

CTI BioPharma Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 7, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	2,105	1,238	1,418	1,252	1,313	761
Market Cap Growth	20.41%	-12.69%	13.31%	-4.67%	72.46%	-69.68%
Enterprise Value	5,208	6,462	6,207	5,824	5,787	5,044
Last Close Price	16.86	9.74	10.63	8.87	8.78	4.74
PE Ratio	-	-	52.53	-	-	-
Forward PE	16.69	-	11.14	14.18	43.26	27.90
PS Ratio	0.72	0.42	0.45	0.45	0.62	0.42
PB Ratio	2.93	0.82	0.83	0.71	0.64	0.42
P/TBV Ratio	-	-	16.83	8.68	6.35	1.96
P/FCF Ratio	-	-	-	-	35.91	4.99
P/OCF Ratio	9.03	3.16	2.72	3.74	3.89	2.57
PEG Ratio	-	-	1.86	1.18	26.06	26.06
EV/Sales Ratio	1.81	2.18	1.95	2.09	2.72	2.76
EV/EBITDA Ratio	9.37	11.35	10.18	10.20	15.01	14.34
EV/EBIT Ratio	19.77	25.23	18.84	21.18	76.45	89.27
EV/FCF Ratio	-	-	-	-	158.30	33.05
Debt / Equity Ratio	4.33	2.87	2.34	2.03	1.51	1.97
Debt / EBITDA Ratio	5.28	7.23	6.16	6.15	7.73	9.29
Debt / FCF Ratio	-	-	-	-	85.39	23.25
Asset Turnover	0.49	0.42	0.48	0.46	0.36	0.29
Inventory Turnover	27.15	19.01	23.45	27.56	18.88	17.16
Quick Ratio	0.81	0.88	0.80	1.03	0.87	1.17
Current Ratio	0.94	1.06	1.00	1.20	1.09	1.51
Return on Equity (ROE)	-5.67%	-2.05%	8.40%	6.73%	-7.14%	-19.06%
Return on Assets (ROA)	2.79%	2.28%	3.08%	2.80%	0.80%	0.56%
Return on Capital (ROIC)	3.50%	2.76%	3.71%	3.26%	0.90%	0.62%
Return on Capital Employed (ROCE)	6.20%	4.10%	5.40%	4.90%	1.40%	1.00%
Earnings Yield	-29.60%	-5.17%	8.30%	6.03%	-12.57%	-54.74%
FCF Yield	-6.83%	-15.77%	-6.97%	-7.17%	2.79%	20.05%
Dividend Yield	3.91%	6.47%	5.64%	6.77%	6.84%	12.65%
Payout Ratio	-	-	142.25%	196.51%	-	-
Buyback Yield / Dilution	0.01%	0.06%	0.04%	-	-	-
Total Shareholder Return	3.85%	6.52%	5.68%	6.77%	6.84%	12.65%

Updated May 8, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q